Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tumor characteristics in immunosuppressed and renal dysfunction populations.

Autor: Joffe BI; Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY., Martina LP; Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY., Stillman M; Columbia University Vagelos College of Physicians and Surgeons, New York, NY., Rust D; Columbia University Vagelos College of Physicians and Surgeons, New York, NY., Gorroochurn P; Mailman School of Public Health, Department of Biostatistics, Columbia University Irving Medical Center, New York, NY., Lenis AT; Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY., DeCastro GJ; Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., McKiernan JM; Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Anderson CB; Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY. Electronic address: cba2125@cumc.columbia.edu.

Publikováno v: Urologic oncology [Urol Oncol] 2024 Dec; Vol. 42 (12), pp. 453.e9-453.e14. Date of Electronic Publication: 2024 Oct 04.

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.

Autor: Hawley JE; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Obradovic AZ; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA., Dallos MC; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Lim EA; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Runcie K; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Ager CR; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA., McKiernan J; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA., Anderson CB; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA., Decastro GJ; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA., Weintraub J; Department of Interventional Radiology, Columbia University Irving Medical Center, New York, NY, USA., Virk R; Department of Pathology, Columbia University Irving Medical Center, New York, NY, USA., Lowy I; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Hu J; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Chaimowitz MG; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA., Guo XV; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA., Zhang Y; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA., Haffner MC; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA, USA., Worley J; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA., Stein MN; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Califano A; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Biochemistry & Molecular Biophysics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032 USA; Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032 USA; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032 USA; J.P. Sulzberger Columbia Genome Center, Columbia University Irving Medical Center, New York, NY 10032 USA. Electronic address: ac2248@cumc.columbia.edu., Drake CG; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Interventional Radiology, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: cgd2139@columbia.edu.

Publikováno v: Cancer cell [Cancer Cell] 2023 Nov 13; Vol. 41 (11), pp. 1972-1988.e5. Date of Electronic Publication: 2023 Nov 02.

A population-based analysis of risk factors and outcomes of prostatic abscess.

Autor: Ha AS; Columbia University Irving Medical Center, Department of Urology, New York, NY, USA. Ah3512@cumc.columbia.edu., Helman TA; University of Central Florida College of Medicine, Orlando, FL, USA., Haas CR; Columbia University Irving Medical Center, Department of Urology, New York, NY, USA., Decastro GJ; Columbia University Irving Medical Center, Department of Urology, New York, NY, USA., Hyams ES; Columbia University Irving Medical Center, Department of Urology, New York, NY, USA.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Dec; Vol. 24 (4), pp. 1143-1150. Date of Electronic Publication: 2021 May 10.